Invesco Ltd. Precision Biosciences Inc Transaction History

Invesco Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.7 - $1.41 $5,588 - $11,256	7,983 Added 46.7%	25,079 $18,000
Q4 2022 Feb 13, 2023	BUY	$0.97 - $45.0 $16,583 - $769,320	17,096 New	17,096 $20,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $26,294 - $76,369	-22,865 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $352 - $923	119 Added 0.52%	22,865 $71,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $10,589 - $16,685	-1,431 Reduced 5.92%	22,746 $168,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $36,187 - $55,779	3,942 Added 19.48%	24,177 $279,000
Q2 2021 Aug 17, 2021	BUY	$8.07 - $12.52 $69,127 - $107,246	8,566 Added 73.41%	20,235 $254,000
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $100,003 - $184,253	11,669 New	11,669 $121,000
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $335,703 - $997,804	-66,476 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $420,128 - $1.31 Million	66,476 New	66,476 $923,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $521M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.